Transdermal technology treatment for women in vials to address the initial stages of hair loss. CaduCrex is effective in preventing and reducing hair loss from physiological, non-pathological causes.

The main active ingredients (Hydroxyproline, Aspartic Acid, Enzymatic Activator, and Taurine) have been tested through transdermal technology (low molecular weight, with 3 action enhancers) to evaluate their penetration into the hair growth system, not only through the follicles (via the hair follicle pore) but also transdermally (ex vivo clinical testing with Franz Cells), meaning through the layers of the scalp skin (epidermis and dermis).

Additionally, the active ingredients of the complex for follicular islands have also been developed with transdermal technology, aiming to reduce hair loss not only in individual follicles but also in follicular islands.